COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Articolo
Data di Pubblicazione:
2020
Citazione:
Jereczek-Fossa, B. A., Pepa, M., Marvaso, G., Bruni, A., Buglione Di Monale E Bastia, M., Catalano, G., Filippi, A. R., Franco, P., Gambacorta, M. A., Genovesi, D., Iati, G., Magli, A., Marafioti, L., Meattini, I., Merlotti, A., Mignogna, M., Musio, D., Pacelli, R., Pergolizzi, S., Tombolini, V., Trovo, M., Ricardi, U., Magrini, S. M., Corvo, R., Donato, V., COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO), <>, 2020; 149 (agosto): 89-93. [doi:10.1016/j.radonc.2020.04.061] [http://hdl.handle.net/10807/198622]
Abstract:
Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
AIRO (Italian Association of Radiotherapy and Clinical Oncology); COVID-19; Italy; Radiation oncology; Survey; COVID-19; Disease Outbreaks; Humans; Italy; Neoplasms; SARS-CoV-2; Surveys and Questionnaires; Betacoronavirus; Coronavirus Infections; Medical Oncology; Pandemics; Pneumonia, Viral
Elenco autori:
Jereczek-Fossa, B. A.; Pepa, M.; Marvaso, G.; Bruni, A.; Buglione di Monale e Bastia, M.; Catalano, G.; Filippi, A. R.; Franco, P.; Gambacorta, Maria Antonietta; Genovesi, D.; Iati, G.; Magli, A.; Marafioti, L.; Meattini, I.; Merlotti, A.; Mignogna, M.; Musio, D.; Pacelli, R.; Pergolizzi, S.; Tombolini, V.; Trovo, M.; Ricardi, U.; Magrini, S. M.; Corvo, R.; Donato, V.
Link alla scheda completa:
Pubblicato in: